Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other financing activities (2020 - 2023)

Rockwell Medical's Other financing activities history spans 5 years, with the latest figure at -$38000.0 for Q4 2023.

  • For Q4 2023, Other financing activities changed N/A year-over-year to -$38000.0; the TTM value through Dec 2024 reached $5000.0, changed 0.0%, while the annual FY2023 figure was $5000.0, 95.28% down from the prior year.
  • Other financing activities reached -$38000.0 in Q4 2023 per RMTI's latest filing, down from $43000.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $969000.0 in Q2 2020 to a low of -$38000.0 in Q4 2023.
  • Average Other financing activities over 3 years is $269675.6, with a median of $43000.0 recorded in 2023.